Bayer Sues Teva Over Generic Yaz
The German drugmaker filed the complaint in the U.S. District Court for the District of Delaware.
The complaint asks the court to delay the release of Teva's generic version of Yaz, which is also marketed as Yasmin, until June 30, 2014, when the asserted patents expire.
The drug, a combination of drospirenone and ethinyl estradiol, is...
To view the full article, register now.